Balkrishan Simba Gill
2021
In 2021, Balkrishan Simba Gill earned a total compensation of $4.2M as Chief Executive Officer at Evelo Biosciences, a 94% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $268,813 |
---|---|
Option Awards | $3,372,930 |
Salary | $575,000 |
Other | $509 |
Total | $4,217,252 |
Gill received $3.4M in option awards, accounting for 80% of the total pay in 2021.
Gill also received $268.8K in non-equity incentive plan, $575K in salary and $509 in other compensation.
Rankings
In 2021, Balkrishan Simba Gill's compensation ranked 3,166th out of 12,415 executives tracked by ExecPay. In other words, Gill earned more than 74.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,166 | 75th |
Manufacturing | 1,277 | 77th |
Chemicals And Allied Products | 522 | 78th |
Drugs | 463 | 78th |
Pharmaceutical Preparations | 320 | 79th |
Gill's colleagues
We found two more compensation records of executives who worked with Balkrishan Simba Gill at Evelo Biosciences in 2021.
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019